G Aranda1,2, M Careaga2, F A Hanzu1,2,3,4, I Patrascioiu2, P Ríos2, M Mora1,2,3,4, B Morales-Romero5, W Jiménez5,6, I Halperin1,2,3,4, G Casals7. 1. Group of Endocrine Disorders, IDIBAPS, Barcelona, Spain. 2. Department of Endocrinology and Nutrition, Hospital Clinic, Barcelona, Spain. 3. Centro de Investigación en Red, CIBERDEM, Barcelona, Spain. 4. University of Barcelona, Barcelona, Spain. 5. Biochemistry and Molecular Genetics Service, Hospital Clinic Universitari, IDIBAPS, CIBERehd, Villarroel 170, 08036, Barcelona, Spain. 6. Biomedicine Department, University of Barcelona, Barcelona, Spain. 7. Biochemistry and Molecular Genetics Service, Hospital Clinic Universitari, IDIBAPS, CIBERehd, Villarroel 170, 08036, Barcelona, Spain. casals@clinic.cat.
Abstract
PURPOSE: Urinary free cortisol (UFC) determination by highly specific methods as mass spectrometry instead of commercially available antibody-based immunoassays is increasingly recommended. However, clinical comparisons of both analytical approaches in the screening of Cushing's syndrome (CS) are not available. The aim of this study was to evaluate the diagnostic value of mass spectrometry versus immunoassay measurements of 24 h-UFC in the screening of CS. METHODS: Cross-sectional study of 33 histologically confirmed CS patients: 25 Cushing's disease, 5 adrenal CS and 3 ectopic CS; 92 non-CS patients; and 35 healthy controls. UFC by immunoassay (UFCxIA) and mass spectrometry (UFCxMS), urinary free cortisone (UFCo) and UFC:UFCo ratio were measured, together with creatinine-corrected values. Sensitivity, specificity, AUC and Landis and Koch concordance index were determined. RESULTS: AUC for UFCxIA and UFCxMS were 0.77 (CI 0.68-0.87) and 0.77 (CI 0.67-0.87) respectively, with a kappa coefficient 0.60 and strong Landis and Koch concordance index. The best calculated cutoff values were 359 nmol/24 h for UFCxIA (78 % sensitivity, 62 % specificity) and 258.1 nmol/24 h for UCFxMS (53 % sensitivity, 86 % specificity). The upper limit of UFCxIA and UCFxMS reference ranges were 344.7 and 169.5 nmol/24 h respectively. Sensitivity and specificity for CS diagnosis at these cutpoints were 84 and 56 % for UFCxIA and 81 and 54 % for UFCxMS. CONCLUSIONS: According to our data, both methods present a very similar diagnostic value. However, results suggest that lower cutoff points for mass spectrometry may be necessary in order to improve clinical sensitivity.
PURPOSE: Urinary free cortisol (UFC) determination by highly specific methods as mass spectrometry instead of commercially available antibody-based immunoassays is increasingly recommended. However, clinical comparisons of both analytical approaches in the screening of Cushing's syndrome (CS) are not available. The aim of this study was to evaluate the diagnostic value of mass spectrometry versus immunoassay measurements of 24 h-UFC in the screening of CS. METHODS: Cross-sectional study of 33 histologically confirmed CS patients: 25 Cushing's disease, 5 adrenal CS and 3 ectopic CS; 92 non-CS patients; and 35 healthy controls. UFC by immunoassay (UFCxIA) and mass spectrometry (UFCxMS), urinary free cortisone (UFCo) and UFC:UFCo ratio were measured, together with creatinine-corrected values. Sensitivity, specificity, AUC and Landis and Koch concordance index were determined. RESULTS: AUC for UFCxIA and UFCxMS were 0.77 (CI 0.68-0.87) and 0.77 (CI 0.67-0.87) respectively, with a kappa coefficient 0.60 and strong Landis and Koch concordance index. The best calculated cutoff values were 359 nmol/24 h for UFCxIA (78 % sensitivity, 62 % specificity) and 258.1 nmol/24 h for UCFxMS (53 % sensitivity, 86 % specificity). The upper limit of UFCxIA and UCFxMS reference ranges were 344.7 and 169.5 nmol/24 h respectively. Sensitivity and specificity for CS diagnosis at these cutpoints were 84 and 56 % for UFCxIA and 81 and 54 % for UFCxMS. CONCLUSIONS: According to our data, both methods present a very similar diagnostic value. However, results suggest that lower cutoff points for mass spectrometry may be necessary in order to improve clinical sensitivity.
Entities:
Keywords:
Cushing’s syndrome; Immunoassay; Mass spectrometry; Urinary free cortisol
Authors: Mohamed B Elamin; M Hassan Murad; Rebecca Mullan; Dana Erickson; Katherine Harris; Sarah Nadeem; Robert Ennis; Patricia J Erwin; Victor M Montori Journal: J Clin Endocrinol Metab Date: 2008-03-11 Impact factor: 5.958
Authors: Judith G M Rosmalen; Ido P Kema; Stefan Wüst; Claude van der Ley; Sipke T Visser; Harold Snieder; Stephan J L Bakker Journal: Psychoneuroendocrinology Date: 2014-05-04 Impact factor: 4.905
Authors: Lisa Wood; David H Ducroq; Helen L Fraser; Scott Gillingwater; Carol Evans; Alan J Pickett; Derek W Rees; Rhys John; Atilla Turkes Journal: Ann Clin Biochem Date: 2008-07 Impact factor: 2.057
Authors: Marta Araujo-Castro; Pablo Valderrábano; Héctor F Escobar-Morreale; Felicia A Hanzu; Gregori Casals Journal: Endocrine Date: 2020-11-21 Impact factor: 3.633
Authors: Femke M van Haalen; Elon H C van Dijk; Olaf M Dekkers; Maurice B Bizino; Greet Dijkman; Nienke R Biermasz; Camiel J F Boon; Alberto M Pereira Journal: Front Endocrinol (Lausanne) Date: 2018-02-20 Impact factor: 5.555